Haleon shares: what the City thinks

22nd September 2022 10:32

by Victoria Scholar from interactive investor

Share on

After shares in the consumer healthcare company jumped to the top of the FTSE 100 this week, Victoria Scholar takes a closer look at Haleon (LSE:HLN) and finds out whether City analysts think it is a buy, hold or sell.

These articles are provided for information purposes only.  Occasionally, an opinion about whether to buy or sell a specific investment may be provided by third parties.  The content is not intended to be a personal recommendation to buy or sell any financial instrument or product, or to adopt any investment strategy as it is not provided based on an assessment of your investing knowledge and experience, your financial situation or your investment objectives. The value of your investments, and the income derived from them, may go down as well as up. You may not get back all the money that you invest. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment adviser.

Full performance can be found on the company or index summary page on the interactive investor website. Simply click on the company's or index name highlighted in the article.

Related Categories

    UK sharesVideos

Get more news and expert articles direct to your inbox